Video Viewpoint on Clinical Debates in Breast Cancer -Advanced ER-Positive Disease Part 1

Video Viewpoint on Clinical Debates in Breast Cancer -Advanced ER-Positive Disease Part 3Подробнее

Video Viewpoint on Clinical Debates in Breast Cancer -Advanced ER-Positive Disease Part 2Подробнее

Drs. Kuerer, Gradishar & McArthur discuss #breastcancer from #ASBrS22 - https://bit.ly/3JOwU1gПодробнее

Understanding Breast CancerПодробнее

DEBATE: RxPONDER: "Was it all OFS?" ProПодробнее

Expert Video Viewpoints on Community Oncology Clinical Debates in Breast Cancer Part 3Подробнее

DEBATES IN ONCOLOGY MANAGEMENT 2021Подробнее

Raising the Bar in HR+/HER2- Early Breast Cancer: CDK4 and 6 InhibitorsПодробнее

Debate IORT vs APBIПодробнее

High-Risk Patient Breast Cancer Case Panel Discussion | 2022 Best of Breast ConferenceПодробнее

2021 San Antonio Breast Cancer Symposium Update on MBC | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

Advanced Hormone Receptor-positive Breast CancerПодробнее

Breast Cancer Screening - The DebateПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Viewpoint: The battle against Metastatic Breast CancerПодробнее

First-Line Treatment of HER2-Positive Metastatic Breast CancerПодробнее

Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast CancerПодробнее

What Changes Monday Morning? | Practice Applications in Breast Cancer | Metastatic DiseaseПодробнее

Biomarkers in Breast Cancer: Current Practice, Opportunities and Unmet NeedsПодробнее